Drug Trial Radar · NCT00798967
Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects
Last checked: Nov 19, 2026Latest source record: Jun 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
86
Actual
Start
Nov 25, 2008
Primary completion
Jan 25, 2011
Study completion Jan 25, 2011
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- Collaborators
- Nycomed
- First posted
- Nov 27, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Teduglutide is an investigative medicine being evaluated as a possible treatment for people with parenteral nutrition (PN) dependent Short Bowel Syndrome (SBS). Teduglutide is similar to a protein the body makes. When people have SBS, their bodies do not make enough of the protein and they have trouble getting nutrients and fluids from the food they eat and drink. This study was designed to provide evidence of efficacy, safety, and tolerability of teduglutide 0.05 mg/kg daily in SBS subjects.
Conditions
- Short Bowel Syndrome
Interventions
teduglutideDrug
0.05 mg/kg/day sc injection for 24 weeks
placeboDrug
Matching daily subcutaneous dose of placebo to teduglutide for 24 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- ResponderTime frame: Weeks 20 and 24
Locations
35 sites in 10 countries. Site status is shown where the registry gives one.
Scripps Clinic & Research Foundation
La Jolla, California
Washington Hospital Center
Washington D.C., District of Columbia
Mayo Clinic Jacksonville
Jacksonville, Florida
Emory University School of Medicine
Atlanta, Georgia
Kansas University Medical Center
Kansas City, Kansas
Mount Sinai Medical Center
New York, New York
Cleveland Clinic Foundation
Cleveland, Ohio
University of Pennslyvania
Philadelphia, Pennsylvania
University Of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Rhode Island Hospital
Providence, Rhode Island
Vanderbilt University Medical Center
Nashville, Tennessee
Critical Care Research, Royal Alexandra Hospital
Edmonton, Alberta, Canada
Hamilton Health Sciences Centre
Hamilton, Ontario, Canada
Polyclinic Family and Specialty Medicine Facility
North York, Ontario, Canada
University Health Network - Toronto General Hospital
Toronto, Ontario, Canada
Rigshospitalet - Abdominalcentret, Hepatologisk Kilinik A
Copenhagen, Denmark
Hôpital Beaujon
Clichy, France
Hôpital Croix Rousse Unité de Nutrition Clinique Intensive
Lyon, France
Hôpital de l'Archet Pôle Digestif
Nice, France
Universitaetsklinikum Tuebingen
Tübingen, Baden-Wurttemberg, Germany
Israelitisches Krankenhaus
Hamburg, Free and Hanseatic City of Hamburg, Germany
Med. Klinik m.S. Hepatologie und Gastroenterologie
Berlin, State of Berlin, Germany
Policlinico Sant'Orsola - Malpighi centro insufficienza intestinale
Bologna, Italy
Azienda Universitaria Policlinico Federico II
Naples, Italy
Azienda Ospedaliera Universitaria S. Giovanni Battista - Le Molinette
Torino, TO, Italy
Universitair Medisch Centrum St. Radboud
Nijmegen, Netherlands
Wojewodzki Szpital Specjalistyczny im. M. Pirogowa, Pracownia Leczenia Zywieniowego
Lodz, Poland
Samodzielny Publiczny Szpital Kliniczny nr 4, Klinika Chirurgii Ogolnej i Transplantacyjnej
Lublin, Poland
Wojewodzki Szpital Specjalistyczny,
Olsztyn, Poland
Samodzielny Publiczny Szpital Kliniczny im. prof W. Orlowskiego CMKP, Oddzial Kliniczny Zywienia i Chirurgii
Warsaw, Poland
Hospital Universitario de Bellvitge
Barcelona, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain
St. Mark's Hospital Northwick Park
Harrow, GT LON, United Kingdom
University College Hospital
London, GT LON, United Kingdom
Green Area, Main Hospital Salford Royal Hospitals NHS Foundation Trust
Manchester, GT MAN, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.